ServiceNow stock is the IBD Stock of the Day ahead of the enterprise software maker's fourth quarter earnings report.
Children who were diagnosed with inflammatory bowel disease (IBD) showed a decline in height, weight, and body mass index ...
A study suggests that adjunct therapies, including the Mediterranean diet, physical activity, and cognitive behavioral ...
Eating a Mediterranean-style diet can help people manage IBD symptoms, and a new cookbook from Crohn's & Colitis Ireland ...
The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...
Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in inflammatory bowel disease (IBD), Mount Sinai researchers have shown in a ...
A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold, potentially eliminating ...
The FDA expanded the approval of mirikizumab (Omvoh) to include treatment of adults with moderately to severely active ...
Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...
Omvoh (mirikizumab-mrkz) for moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for ...
Catalyst struck a deal Wednesday with Teva that will prevent the generic drugmaker from knocking off Firdapse until 2035.
If you have an inflammatory bowel disease like Crohn’s or ulcerative colitis and have trouble focusing or remembering things, ...